Tianjin Medical University Second Hospital

New phase 2 trial NCT06739395 posted by Tianjin Medical University Second Hospital: "Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion". New trial on a phase 2 recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 629 days ago.

NextMap clinical development and translational medicine stakeholders on the sponsor, confirm no colleague is mid-conversation, then draft evidence-based outreach.

New phase 2 trial NCT07170293 posted by Tianjin Medical University Second Hospital: "Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors". New trial on a phase 2 recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 361 days ago.

NextHold. Score is below the tenant threshold (55). Keep on the watchlist for follow-on signals.